.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
QuintilesIMS
Novartis
McKinsey
Accenture
Healthtrust
AstraZeneca
UBS
Mallinckrodt
McKesson

Generated: June 27, 2017

DrugPatentWatch Database Preview

Anagrelide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for anagrelide hydrochloride and what is the scope of anagrelide hydrochloride patent protection?

Anagrelide hydrochloride
is the generic ingredient in two branded drugs marketed by Impax Labs, Mylan Pharms Inc, Watson Labs, Barr, Shire Llc, Ivax Sub Teva Pharms, Upsher-smith Labs, and Roxane, and is included in nine NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for anagrelide hydrochloride. Five suppliers are listed for this compound.

Summary for Generic Name: anagrelide hydrochloride

Tradenames:2
Patents:1
Applicants:8
NDAs:9
Drug Master File Entries: see list8
Suppliers / Packagers: see list5
Bulk Api Vendors: see list52
Clinical Trials: see list2,253
Patent Applications: see list529
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:anagrelide hydrochloride at DailyMed

Pharmacology for Ingredient: anagrelide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs
ANAGRELIDE HYDROCHLORIDE
anagrelide hydrochloride
CAPSULE;ORAL076910-002Apr 18, 2005ABRXNoNo► Subscribe► Subscribe
Shire Llc
AGRYLIN
anagrelide hydrochloride
CAPSULE;ORAL020333-002Mar 14, 1997DISCNYesNo► Subscribe► Subscribe
Mylan Pharms Inc
ANAGRELIDE HYDROCHLORIDE
anagrelide hydrochloride
CAPSULE;ORAL077613-001Jun 27, 2006DISCNNoNo► Subscribe► Subscribe
Watson Labs
ANAGRELIDE HYDROCHLORIDE
anagrelide hydrochloride
CAPSULE;ORAL076417-002Apr 18, 2005DISCNNoNo► Subscribe► Subscribe
Shire Llc
AGRYLIN
anagrelide hydrochloride
CAPSULE;ORAL020333-001Mar 14, 1997ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
AstraZeneca
Deloitte
Merck
Dow
Fuji
Julphar
Chinese Patent Office
UBS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot